BJDX - Bluejay Diagnostics, Inc.

1.86
-0.040   -2.151%

Share volume: 57,622
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$1.90
-0.04
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 35%
Dept financing 29%
Liquidity 50%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.62%
1 Month
-40.38%
3 Months
61.74%
6 Months
30.07%
1 Year
-55.18%
2 Year
111.68%
Key data
Stock price
$1.86
P/E Ratio 
0.00
DAY RANGE
$1.78 - $1.90
EPS 
-$9.66
52 WEEK RANGE
$0.63 - $10.20
52 WEEK CHANGE
-$55.18
MARKET CAP 
2.393 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
2.97
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$441,239
AVERAGE 30 VOLUME 
$570,401
Company detail
CEO: Indranil Dey
Region: US
Website: bluejaydx.com
Employees: 9
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Bluejay Diagnostics, Inc. develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis.

Recent news